Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
New Tool Launches to Support Women Through Post-Loss Journey
Carea has introduced a free "Healing After Loss" mode within its pregnancy and postnatal wellbeing app, offering on‑demand mental‑health tools, expert guidance, and a peer community for women who have experienced miscarriage or baby loss. The feature activates automatically when users report a loss and can also be accessed without sharing personal details. It aims to fill a recognized gap in UK healthcare, where many women face clinical detachment and long waits for support. The launch aligns with recent policy attention from the UK Health Secretary and Scotland’s miscarriage charter.
Senators Grill RFK Jr. On Vaccines, Drug Prices and More at Hearing
Health Secretary Robert F. Kennedy Jr. faced intense questioning from Senate Finance and HELP committees, with Democrats probing his vaccine policies, promotional video costs, and the TrumpRx drug‑discount platform. Republicans highlighted his rural health initiatives and progress on food‑dye reductions,...
Amazon Just Put the Biggest Trade of the Decade on the Wrong Side—And Big Pharma Is Paying for It
Amazon has launched a direct‑to‑patient pricing model for GLP‑1 drugs, offering cash‑pay rates of $25 per month for insured patients, $149 for oral pills and $299 for injectables such as Wegovy and Zepbound. The pricing, combined with same‑day delivery to...
They’re in Remission, but Their Medical Bills Aren’t: Cancer Survivors Navigate Soaring Costs
Cancer survivors in the United States are confronting soaring out‑of‑pocket expenses even after remission. The article follows Marielle Santos McLeod, who continues to pay thousands in chemotherapy and follow‑up bills, and cites a 2024 survey showing 47 % of survivors carry medical...
Montana Moves Ahead With Doula Pay but Warns Medicaid Cuts Still May Come
Montana officials reversed a pause and are moving ahead with a plan to reimburse doulas through Medicaid, estimating a first‑year cost of about $118,000. The initiative, approved by lawmakers last year, still requires federal approval before payments can start. State...
On‐Chip Evaluation of Red Blood Cell Deformability Through Transit Velocity Index in Hematological Diseases
Researchers have introduced a microfluidic platform that measures red blood cell (RBC) deformability using a transit velocity index (V^ε=0.5) derived from capillary‑like constrictions. The index reliably tracks stiffness changes when RBCs are chemically stiffened with diamide, confirming its sensitivity. Applying...
Genentech Reports the P-III (METEOROID) Trial Data on Enspryng (Satralizumab) to Treat MOGAD
Genentech presented Phase III METEOROID trial results for Enspryng (satralizumab) in patients aged 12 and older with myelin oligodendrocyte glycoprotein antibody‑associated disease (MOGAD). The study met its primary endpoint, showing 87% of participants remained relapse‑free at 48 weeks versus 67%...
Firefighters to Get Regular Health Checks Under New ‘Concordat’
The UK government has signed a Firefighters Concordat on Health and Wellbeing, committing to regular health checks for all firefighters and new research funding. Health and Social Care Secretary Wes Streeting and Building Safety Minister Samantha Dixon announced the initiative...
Dayne Williams, Quantum Health
Quantum Health, a leading employee health navigation firm, appointed Dayne Williams as CEO after Zane Burke retired for personal reasons. Williams returns from retirement to steer the company following recent acquisitions of Embold Health, a doctor‑ranking analytics platform, and CirrusMD,...
Artera’s Prostate Biopsy and Breast Cancer Assays Receive CE Mark
Artera announced that its ArteraAI prostate biopsy and breast cancer assays have received CE marking under the EU In Vitro Diagnostic Regulation, expanding the company’s reach to the European market. The prostate assay is the first AI‑enabled prognostic and predictive test...
AI Chatbots Recommending Chemo Alternatives, Study Warns
A study by the Lundquist Institute evaluated major AI chatbots—including Grok, ChatGPT, Gemini, Meta AI and DeepSeek—on cancer‑treatment queries. Experts rated almost half of the responses as problematic, with 30% deemed somewhat inaccurate and 19.6% highly misleading. The bots often...
PARP Inhibitors: A Proven Class Facing Limits
PARP inhibitors have reshaped treatment for BRCA‑mutated cancers by exploiting synthetic lethality, but their expansion beyond this niche faces hurdles. While ovarian, breast, pancreatic, and prostate indications now include PARP‑based maintenance or combination regimens, inconsistent benefits in HRD‑positive and broader...
PSN Manufacturing Earns ISO 9001 and 13485 Certifications
PSN Manufacturing announced it has earned ISO 9001:2015 and ISO 13485:2016 certifications, confirming a robust quality management system for both general manufacturing and regulated medical‑device components. The company’s 100% climate‑controlled plant features a Class 8 cleanroom, a flexible molding floor for 50‑500 ton machines,...
How Indian Families Can Optimise Floater Health Plans
Indian families are urged to treat floater health insurance as a strategic, not just a convenience, purchase. The article outlines how aligning policy structure with age mix, medical needs, and potential claim overlap can improve coverage efficiency. It stresses the...
Roche Reports Phase III METEOROID Study Results for MOGAD
Roche announced that its subcutaneous antibody satralizumab, marketed as Enspryng, achieved a 68% reduction in relapse risk in the Phase III METEOROID trial for myelin oligodendrocyte glycoprotein antibody‑associated disease (MOGAD). At 48 weeks, 87% of patients on Enspryng remained relapse‑free versus...
Register for HTN Now Webinars, Covering AVT in Trusts, Digital Patient Pathways, AI in Primary Care, 10 Year Plan From...
HTN is launching a series of free, online webinars for NHS professionals that run from late April through May. Each session deep‑dives into a specific digital‑health topic, from ambient‑scribe AI and paperless NHS initiatives to AI in primary care and...
Sanofi Reports the US FDA Approval of Tzield to Delay Onset of Stage 3 Type 1 Diabetes in Children (≥1years)
Sanofi’s monoclonal antibody Tzield (teplizumab‑mzwv) received U.S. FDA approval under priority review to delay the onset of stage 3 type 1 diabetes (T1D) in children as young as one year who are diagnosed with stage 2 disease. The decision was driven by one‑year...
National Commission Into the Regulation of AI in Healthcare Offers Early Insights From Call for Evidence
The UK National Commission into the Regulation of AI in Healthcare released early findings from a call for evidence that attracted more than 770 responses, underscoring strong public demand for regulatory reform. Deputy chair Henrietta Hughes emphasized trust, post‑market surveillance,...
New "Plug-and-Play" AI Outperforms Pathologists in Lymph Node Metastasis Detection
HKUST researchers unveiled PRET, a plug‑and‑play AI pathology system that learns new cancer types from just one to eight annotated slides. The model achieved AUC scores above 97% on 15 of 20 benchmark tasks, including a perfect 100% for colorectal...
Lentinan‐Enhanced Mn3O4 Nanoparticles for Neuroinflammation Relief and Parkinson's Disease Treatment
Researchers have engineered a lentinan‑coated manganese oxide (Mn3O4@LNT) nanoparticle that can circulate long‑term and cross the blood‑brain barrier (BBB). Proteomic analysis revealed that the LNT coating reshapes the particle’s protein corona, enhancing BBB traversal and brain accumulation. In cellular and...
The World’s First RealTime AI Assistant for Pancreatic EUS, Available for Clinical Use in the UK.
Fannin UK has launched mAI Companion®, a real‑time AI assistant for pancreatic endoscopic ultrasound (EUS) that received MDR CE Mark approval, making it the first AI‑driven EUS tool cleared for clinical use in the UK. Developed with IHU‑Strasbourg and trained...
Roche’s Fenebrutinib Cuts Relapses in MS Amid Safety Concerns
Roche’s investigational BTK inhibitor fenebrutinib achieved 51.1% and 58.5% reductions in annualised relapse rates versus teriflunomide in the Phase III FENhance 1 and 2 trials for relapsing multiple sclerosis, while also cutting MRI lesion activity. The drug showed encouraging trends in disability‑progression measures...
Bad Sleep Drives Depression and Insulin Resistance, Not Just Symptom
One of the most expensive mistakes in health is treating bad sleep as a side effect. Very often, it is part of the mechanism. A new study on depression and insulin resistance caught my attention. Link at the end. I will walk...
Merck Reports the US FDA Approval of Idvynso for Virologically Suppressed HIV-1 Infection
Merck’s Idvynso, a once‑daily tablet combining 100 mg doravirine with 0.25 mg islatravir, received FDA approval as a switch regimen for virologically suppressed HIV‑1 adults. The approval rests on two Phase III trials—Trial 052 (n=513) and Trial 051 (n=551)—which demonstrated comparable viral suppression to existing...
Oscar Health Turns Health Insurance Into Consumer Marketplace
Airbnb for healthcare?? Oscar Health has an interesting history. They were the first health insurance company to give clients a health tracker. If they proved through data that they lived an active life, they received benefits and rewards. As healthcare is the...
Taste Alterations in Breast Cancer Patients Undergoing Chemotherapy: An Observational Study
A prospective study at Italy’s Candiolo Cancer Institute enrolled 94 breast‑cancer patients, with 70 completing chemotherapy and taste assessments. Subjective questionnaires showed a marked decline in all taste modalities after treatment, while objective taste‑strip testing identified hypogeusia in roughly one‑third...
The Effect of Breast Massage Combined with Co-Parenting Interventions on Breastfeeding in Mother-Infant Separated Mothers: A Quasi-Experimental Study
A quasi‑experimental trial involving 120 mother‑infant dyads separated after birth tested a co‑parenting protocol where fathers performed structured breast massage. The intervention group achieved exclusive breastfeeding rates of 64.9% at one month and 64.3% at three months, far surpassing the...
Hypoallergenicity of a Hydrolyzed Rice Protein-Based Formula Containing 2-Fucosyllactose and Lacto-N-Neotetraose in Children with Cow’s Milk Allergy: Protocol for a...
The RIGHT‑HY study is a multicenter, double‑blind, crossover trial evaluating a hydrolyzed rice protein formula enriched with the human milk oligosaccharides 2‑fucosyllactose and lacto‑N‑neotetraose (HRF‑HMO) in children aged 60 days to 3 years with IgE‑mediated cow’s milk allergy (CMA). Up to 67...
Salvador Marino at ACUD Galerie, Berlin
Salvador Marino’s "Iron Stream" installation opened at ACUD Galerie in Berlin, using sci‑fi‑inspired medical devices to interrogate the blood industry’s capitalist underpinnings. The work juxtaposes health benefits of donation with necropolitical questions about whose lives are saved and at what cost. Market...
New Algorithms Help Surgeons Make High-Stakes Transplant Decisions in Minutes
Researchers at the ISHLT meeting unveiled AI tools designed to speed heart‑transplant decisions, aiming to cut the 15‑30 minute evaluation window. The flagship model, TOPHAT, analyzes 20 donor variables to predict a center’s likelihood of accepting a heart, while a...
Alignment Health Plan CEO: Sometimes When MA Plan Is Pulling Out, the Provider Is to Blame
Medicare Advantage (MA) plans are retreating from markets as hospitals demand excessive reimbursement, prompting a "fundamental reset" in the sector. Alignment Health Plan CEO Dawn Maroney argued that hospital systems, not insurers, are the primary cause of plan pull‑outs, citing...
Lupin Launches Generic Diabetes Drug in US After USFDA Approval
Indian pharma Lupin Ltd received FDA approval for its generic dapagliflozin‑metformin extended‑release tablets and launched them in the United States. The product matches the brand Xigduo XR in bioequivalence and is offered in four strength combinations. The launch adds a lower‑cost...
From Brain Implant to Lifelong Companion: Michel Maharbiz Unveils Epia Neuro
Epia Neuro, a stealth‑mode neurotechnology startup co‑founded by Michel Maharbiz, announced its public debut at the Bioelectronic Medicine Forum. The company, now 45‑strong and backed by venture and pharma investors, is developing a skull‑mounted, dura‑sparing neural interface designed for outpatient...
Purdue’s $5.5B Sentencing for Opioid Charges Delayed After Victims Show at Court
A federal judge postponed Purdue Pharma's criminal sentencing by a week to accommodate in‑person victim testimony after protesters arrived at the courtroom. The delayed hearing will still consider Purdue's 2020 guilty plea, which carries a $3.5 billion criminal fine and $2 billion...
From Governance to Enablement: How Healthcare CIOs Can Stop Killing AI Innovation
Healthcare CIOs risk stifling AI projects by treating governance as a barrier. Tony Pastorino argues that rebranding oversight as data enablement and forming cross‑functional teams can unlock responsible innovation. He advises separating idea generation from compliance checks and focusing on...
CNN Hunts Real Patient Stories on ChatGPT Health Use
It must be a milestone if CNN is actively looking for patient stories of using ChatGPT for health issues. Using generative AI is not newsworthy enough to be covered frequently. Also, there are many patient stories out there proving that...
Billionaires Drive Biotech's Race for Cancer Blockbusters
Just read "For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug" a good book about developing of a pair of cancer drugs. Great work by @nathanvardi https://t.co/rrTOe6GqIB
Shanghai Alcohol Warning Label Trials in Full Swing Across Online and Offline Sales
Shanghai's Municipal Health Commission has launched a citywide pilot requiring warning labels on every alcoholic beverage containing more than 0.5% alcohol by volume. The regulations mandate eye‑level, rectangular signs of specific dimensions in physical stores and prominent electronic warnings on...
Radiologists Collect $90M in Research Funding From Imaging Industry, with Overall Share of Pie Falling
Radiologists secured just over $90 million in industry‑sponsored research payments in 2024, but their slice of the roughly $8.5 billion imaging‑industry funding pool shrank to about 1.1 % from 1.3 % in 2019. The payments, spread across nearly 5,800 transactions, were dominated by oncology...
Viewpoint — Politicization of Public Health: What’s the Impact of the White House Strategy on Children
The article warns that the politicization of public health under the Trump administration, amplified by anti‑vaccine rhetoric from figures like Robert F. Kennedy Jr., is eroding the measles eradication achieved in 2000. Federal vaccine mandates are being rolled back, and...
The Vigil of Care: Kathryn Jenzer and the Courage to Stand Beside Suffering
Kathryn Jenzer, RN, CCRN, serves as the Enhanced Recovery After Surgery (ERAS) Coordinator at the University of Rochester Medical Center, where she designs evidence‑based pathways that speed surgical recovery and lower complications. Her journey from a teenage volunteer in Togo...
The Hospital Math Ain't Mathing
U.S. hospitals are confronting a financial squeeze as payments from Medicare and Medicaid fail to keep pace with rising operating costs. In Arkansas, more than 70% of counties have lost birthing hospitals, and rural facilities nationwide are cutting services or...
Re: Accuracy of Glomerular Filtration Rate Estimation Based on Creatinine and Cystatin C for Monitoring Moderate Chronic Kidney Disease in...
A prospective longitudinal cohort study by Scandrett et al. evaluated creatinine‑only, cystatin C‑only, and combined creatinine‑cystatin C equations for estimating glomerular filtration rate (eGFR) in adults with moderate chronic kidney disease. The dual‑marker equations showed superior performance in tracking GFR decline compared with...
Goodwin Guides Obsidian‑Galera Merger Backed by $350 Million Private Placement
Goodwin Procter LLP advised Obsidian Therapeutics on its all‑stock merger with Galera Therapeutics, a deal underpinned by an oversubscribed $350 million private placement. The financing is slated to close just before the merger, extending the combined company's runway into late 2028...
Why Eating Disorder Recovery Is About More than What You Eat or Weigh
A recent study of 234 adults with eating disorders reveals a stark gap between clinical definitions of recovery and patients' own sense of progress. While only 22.6% met traditional symptom‑based criteria, 52.1% described personal recovery, citing self‑acceptance, hope and stronger...
SynbioTech's L. Plantarum FS4722 Emerges as a Potential Preventive Approach for Hyperuricemia
SynbioTech announced that its probiotic Lactiplantibacillus plantarum FS4722 markedly lowers serum uric acid in mouse models, matching the efficacy of conventional uric‑lowering drugs while showing no kidney toxicity. The strain works through a multi‑mechanism gut‑liver‑kidney axis: it reduces intestinal purine...
UnitedHealth Stock Jumps as Earnings and Outlook Top Expectations
UnitedHealth Group reported first‑quarter 2026 revenue of $111.7 billion, up 2% year‑over‑year, and earnings of $6.90 per share, with adjusted EPS of $7.23. The company lowered its medical‑care ratio to 83.9%, signaling better cost control. It also raised its full‑year EPS...
Blocking PGAM‑Chk1 Kills Senescent Cells, Eases Lung Fibrosis
Researchers found that senescent cells depend on a PGAM–Chk1 interaction to boost glycolysis and survive, and blocking this interaction selectively kills these cells and reduces disease effects like lung fibrosis. https://t.co/VTsHTkBcad
Multi-Regional Trials Have yet to Become the Norm
BioCentury’s website outlines a comprehensive cookie policy that categorises cookies into strictly necessary, functional, marketing, advertising, and analytics types. Strictly necessary cookies are always active and essential for authentication and site navigation, while functional cookies enable enhanced personalization. Marketing and...
Robert F. Kennedy Jr. Defends Spending Cuts to Health Agencies
President Trump’s FY 2027 budget proposes a $111.1 billion allocation for HHS, a 12.5% cut from the current year that would slash NIH research grants and programs for women and children. HHS Secretary Robert F. Kennedy Jr. defended the reductions, arguing that many...